Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
CERO THERAPEUTICS HOLDINGS, INC.
CERO
Other
Warrant Valued Black Scholes
Material Weakness In Internal Controls Disclosed
Capital Raising Uncertainty Disclosed
Nasdaq Minimum Bid Price Delisting Notice
Patent Family Portfolio Disclosure
Patient Retention High
Net Loss Reported
Competition Disclosure
Public Float Disclosure
Cybersecurity Risk Management Program Disclosure
Restrictive Debt Covenants Disclosure
Headcount Disclosure Standard
Core
Clinical Trial Result
Regulatory Designation Only
Secondary Endpoint Mentioned
Other
Form S3 Shelf Registration Disclosure
Convertible Debt Conversion